FDA chides Indiana pain management doc for unapproved human experiments

FDA regulators warn Indiana's Dr. Pattanam Srinivasan for conducting unapproved clinical trials in which he is the sponsor, investigator and head of the independent review board.

FDA regulators this month unveiled a series of warning letters issued to Dr. Pattanam Srinivasan, saying that the doctor authorized, sponsored and oversaw unapproved human experiments at the Indiana-based Advanced Interventional Pain Center.

Advanced Interventional Pain Center, Food & Drug Administration (FDA)

News Well, Clinical Trials, Patient Safety, Food & Drug Administration (FDA), Regulatory/Compliance, Warning Letter

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1fqi4OC